FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dextrose 5% Injection Bags
Status: Currently in Shortage
»Date first posted: 05/19/2014
»Therapeutic Categories: Gastroenterology; Other; Pediatric

Expand all

B. Braun Medical Inc. (Revised 06/18/2015)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5% Dextrose 1000 mL (NDC 0264-7510-00) Continued intermittent interruptions in supply, allocating to contracted customers. Intermittent backorder due to increased product demand. Please see Dear B. Braun IV Solution Customer Letter

Dear B. Braun IV Solution Customer Letter

Demand increase for the drug
5% Dextrose 250 mL (NDC 0264-7510-20) Continued intermittent interruptions in supply, allocating to contracted customers. Intermittent backorder due to increased product demand. Please see Dear B. Braun IV Solution Customer Letter

Dear B. Braun IV Solution Customer Letter

Demand increase for the drug

Baxter Healthcare (Reverified 07/27/2016)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
150 mL VIAFLEX container (NDC 0338-0017-01) Unavailable. Production is planned to resume in 1Q 2016. Please see Dear Valued Baxter Customer Letter dated March 12, 2014 for additional information

Dear Valued Baxter Customer Letter

Demand increase for the drug
250 mL VIAFLEX container (NDC 0338-0017-02) Available Please see Dear Valued Baxter Customer Letter dated March 12, 2014 for additional information

Dear Valued Baxter Customer Letter

Demand increase for the drug
500 mL VIAFLEX container (NDC 0338-0017-03) Available Please see Dear Valued Baxter Customer Letter dated March 12, 2014 for additional information

Dear Valued Baxter Customer Letter

Demand increase for the drug
1000 mL VIAFLEX container (NDC 0338-0017-04) Available for current customers. Please see Dear Valued Baxter Customer Letter dated March 12, 2014 for additional information

Dear Valued Baxter Customer Letter

Demand increase for the drug
250 mL AVIVA non-PVC container (NDC 0338-6346-02) Available for current customers. Please see Dear Valued Baxter Customer Letter dated March 12, 2014 for additional information

Dear Valued Baxter Customer Letter

Demand increase for the drug
500 mL AVIVA non-PVC container (NDC 0338-6346-03) Available for current customers. Please see Dear Valued Baxter Customer Letter dated March 12, 2014 for additional information

Dear Valued Baxter Customer Letter

Demand increase for the drug

Hospira, Inc. (Reverified 07/14/2016)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5% 150 mL Flexible Container (NDC 0409-7922-61) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available Other
5% 250 mL ADD-Vantage Flexible Container (NDC 0409-7100-02) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available. Other
5% 250 mL Flexible Container (2 port) (NDC 0409-7922-02) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available. Other
5% 250 mL VisIV Flexible Container (NDC 0409-7922-25) Available Shortage per Manufacturer: Available. Other
5% 500 mL Flexible Container (NDC 0409-7922-03) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available. Other
5% 500 mL Flexible Container (2 port) (NDC 0409-7922-55) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available. Other
5% 1000 mL Flexible Container (NDC 0409-7922-09) Available Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.